Health at a Glance: Asia/Pacific 2022

Measuring Progress Towards Universal Health Coverage

image of Health at a Glance: Asia/Pacific 2022

This seventh edition of Health at a Glance Asia/Pacific presents a set of key indicators of health status, the determinants of health, health-care resources and utilisation, health-care expenditure and financing, and quality of care across 27 Asia-Pacific countries and territories. It also provides a series of dashboards to compare performance across countries and territories, and a thematic analysis on the health impact of COVID-19. Drawing on a wide range of data sources, it builds on the format used in previous editions of Health at a Glance, and gives readers a better understanding of the factors that affect the health of populations and the performance of health systems in these countries and territories. Each of the indicators is presented in a user-friendly format, consisting of charts illustrating variations across countries and territories, and over time, brief descriptive analyses highlighting the major findings conveyed by the data, and a methodological box on the definition of the indicators and any limitations in data comparability. An annex provides additional information on the demographic and economic context in which health systems operate.


Vaccination, survival and mortality for cervical cancer

According to estimates based on the pre‑pandemic trend, about 337 000 women in Asia-Pacific countries and territories were expected newly diagnosed with cervical cancer in 2020 (IARC, 2022[19]; see indicator on “Cancer incidence” in Chapter 3), although invasive cervical cancer is preventable if pre‑cancerous or pre‑invasive changes are detected and treated before progression occurs. WHO recommends human papilloma virus (HPV) vaccination for girls aged 9‑14 years (WHO, 2017[1]) since vaccination against the main types of HPV responsible for cervical cancer is expected to effectively reduce incidence.



This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error